Related Articles
MicroRNA expression profiles in benign prostatic hyperplasia
miR-20b-5p is a novel biomarker for detecting prostate cancer
BCL9, a coactivator for Wnt/β‑catenin transcription, is targeted by miR‑30c and is associated with prostate cancer progression
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance